121 related articles for article (PubMed ID: 15569251)
1. Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms.
Gu M; Iravani MM; Cooper JM; King D; Jenner P; Schapira AH
J Neurochem; 2004 Dec; 91(5):1075-81. PubMed ID: 15569251
[TBL] [Abstract][Full Text] [Related]
2. Salvianic acid A protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity.
Wang XJ; Xu JX
Neurosci Res; 2005 Feb; 51(2):129-38. PubMed ID: 15681030
[TBL] [Abstract][Full Text] [Related]
3. Involvement of dopamine D(2)/D(3) receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells.
Presgraves SP; Borwege S; Millan MJ; Joyce JN
Exp Neurol; 2004 Nov; 190(1):157-70. PubMed ID: 15473989
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells.
Kitamura Y; Kosaka T; Kakimura JI; Matsuoka Y; Kohno Y; Nomura Y; Taniguchi T
Mol Pharmacol; 1998 Dec; 54(6):1046-54. PubMed ID: 9855633
[TBL] [Abstract][Full Text] [Related]
5. Wild-type alpha-synuclein interacts with pro-apoptotic proteins PKCdelta and BAD to protect dopaminergic neuronal cells against MPP+-induced apoptotic cell death.
Kaul S; Anantharam V; Kanthasamy A; Kanthasamy AG
Brain Res Mol Brain Res; 2005 Sep; 139(1):137-52. PubMed ID: 15978696
[TBL] [Abstract][Full Text] [Related]
6. D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease.
Imamura K; Takeshima T; Kashiwaya Y; Nakaso K; Nakashima K
J Neurosci Res; 2006 Nov; 84(6):1376-84. PubMed ID: 16917840
[TBL] [Abstract][Full Text] [Related]
7. Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response.
Iravani MM; Sadeghian M; Leung CC; Tel BC; Rose S; Schapira AH; Jenner P
Exp Neurol; 2008 Aug; 212(2):522-31. PubMed ID: 18571649
[TBL] [Abstract][Full Text] [Related]
8. Heat shock proteins reduce toxicity of 1-methyl-4-phenylpyridinium ion in SK-N-SH cells.
Fan GH; Qi C; Chen SD
J Neurosci Res; 2005 Nov; 82(4):551-62. PubMed ID: 16235253
[TBL] [Abstract][Full Text] [Related]
9. Pramipexole has astrocyte-mediated neuroprotective effects against lactacystin toxicity.
Imamura K; Takeshima T; Nakaso K; Ito S; Nakashima K
Neurosci Lett; 2008 Aug; 440(2):97-102. PubMed ID: 18555604
[TBL] [Abstract][Full Text] [Related]
10. Pramipexole protects against H2O2-induced PC12 cell death.
Fujita Y; Izawa Y; Ali N; Kanematsu Y; Tsuchiya K; Hamano S; Tamaki T; Yoshizumi M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):257-66. PubMed ID: 16362428
[TBL] [Abstract][Full Text] [Related]
11. Fraxetin prevents rotenone-induced apoptosis by induction of endogenous glutathione in human neuroblastoma cells.
Sánchez-Reus MI; Peinado II; Molina-Jiménez MF; Benedí J
Neurosci Res; 2005 Sep; 53(1):48-56. PubMed ID: 15996779
[TBL] [Abstract][Full Text] [Related]
12. Pramipexole protects against MPTP toxicity in non-human primates.
Iravani MM; Haddon CO; Cooper JM; Jenner P; Schapira AH
J Neurochem; 2006 Mar; 96(5):1315-21. PubMed ID: 16464239
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cyclin-dependent kinases is neuroprotective in 1-methyl-4-phenylpyridinium-induced apoptosis in neurons.
Alvira D; Tajes M; Verdaguer E; de Arriba SG; Allgaier C; Matute C; Trullas R; Jiménez A; Pallàs M; Camins A
Neuroscience; 2007 Apr; 146(1):350-65. PubMed ID: 17343987
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of MPP+-induced mitochondrial damage and cell death by trifluoperazine and W-7 in PC12 cells.
Lee CS; Park SY; Ko HH; Song JH; Shin YK; Han ES
Neurochem Int; 2005 Jan; 46(2):169-78. PubMed ID: 15627517
[TBL] [Abstract][Full Text] [Related]
15. Econazole attenuates cytotoxicity of 1-methyl-4-phenylpyridinium by suppressing mitochondrial membrane permeability transition.
Lee CS; Yim SB; Song JH; Han ES
Brain Res Bull; 2006 May; 69(6):687-94. PubMed ID: 16716839
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of bromocriptine against BH4-induced Cath.a cell death involving up-regulation of antioxidant enzymes.
Lim JH; Kim SS; Boo DH; No H; Kang BY; Kim EM; Hwang O; Choi HJ
Neurosci Lett; 2009 Feb; 451(3):185-9. PubMed ID: 19146917
[TBL] [Abstract][Full Text] [Related]
17. Novel imine antioxidants at low nanomolar concentrations protect dopaminergic cells from oxidative neurotoxicity.
Hajieva P; Mocko JB; Moosmann B; Behl C
J Neurochem; 2009 Jul; 110(1):118-32. PubMed ID: 19486265
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q10.
Moon Y; Lee KH; Park JH; Geum D; Kim K
J Neurochem; 2005 Jun; 93(5):1199-208. PubMed ID: 15934940
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal anti-inflammatory drugs potentiate 1-methyl-4-phenylpyridinium (MPP+)-induced cell death by promoting the intracellular accumulation of MPP+ in PC12 cells.
Morioka N; Kumagai K; Morita K; Kitayama S; Dohi T
J Pharmacol Exp Ther; 2004 Aug; 310(2):800-7. PubMed ID: 15131242
[TBL] [Abstract][Full Text] [Related]
20. Novel neuroprotective mechanisms of pramipexole, an anti-Parkinson drug, against endogenous dopamine-mediated excitotoxicity.
Izumi Y; Sawada H; Yamamoto N; Kume T; Katsuki H; Shimohama S; Akaike A
Eur J Pharmacol; 2007 Feb; 557(2-3):132-40. PubMed ID: 17161393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
